Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 10 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

70%

7 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 3
7(70.0%)
N/A
3(30.0%)
10Total
Phase 3(7)
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (10)

Showing 10 of 10 trials
NCT04698590Not ApplicableActive Not Recruiting

Wavefront Guided Scleral Lenses for Keratoconus and Irregular Astigmatism

Role: lead

NCT01464268Phase 3Unknown

Transepithelial Corneal Collagen Crosslinking for Keratoconus and Corneal Ectasia

Role: lead

NCT02649738Not ApplicableUnknown

Corneal Tissue Inlay for Keratoconus

Role: lead

NCT01112072Phase 3Unknown

Corneal Collagen Crosslinking and Intacs for Keratoconus and Ectasia

Role: lead

NCT01152541Phase 3Unknown

Corneal Collagen Crosslinking for Progressive Keratoconus and Ectasia Using Riboflavin/Dextran and Hypotonic Riboflavin

Role: lead

NCT04905108Phase 3Unknown

Transepithelial (Epi-on) Corneal Collagen Crosslinking to Treat Keratoconus and Corneal Ectasia

Role: lead

NCT04897503Phase 3Unknown

Corneal Collagen Crosslinking for Keratoconus and Ectasia Using Riboflavin/Dextran or Riboflavin/Methylcellulose

Role: lead

NCT05027295Phase 3Unknown

Accelerated Corneal Collagen Crosslinking for Keratoconus and Ectasia Using Pulse or Continuous UV-A Light

Role: lead

NCT04895514Not ApplicableUnknown

Gamma-Irradiated Corneal Inlay for Keratoconus

Role: lead

NCT01672814Phase 3Completed

Microwave Treatment and Corneal Collagen Crosslinking for Keratoconus

Role: lead

All 10 trials loaded